Ask the Experts: Renal and Urology News

Expert Perspectives


Brian Helfand MD PhD

Germline Testing for Prostate Cancer Active Surveillance

Brian T. Helfand, MD, PhD, discussed germline testing for prostate cancer prognosis and its implications for active surveillance at the Philadelphia Prostate Cancer Consensus Conference: Implementation of Genetic Testing for Inherited Prostate Cancer.

Pharmacologic Therapy for CRPC

At the 2019 annual meeting of the American Urological Association (AUA), Dr Jarrard was a member of the instructional faculty in a session titled “AUA Castration Resistant Prostate Cancer (CRPC) Guidelines and Therapeutic Advances in Metastatic Prostate Cancer.”

The New mCRPC Drugs

What have you learned about the differences in tolerability of the newer agents, adverse event profiles, and cost?